Medeva, Wyeth-Ayerst deal

MDV will acquire the intellectual property and exclusive U.S. distribution rights for Wyeth-Ayerst's tetanus and diphtheria/tetanus vaccines. The London company will pay $9.2 million in cash upon completion of the deal. Annual U.S. sales of the vaccines are $9 million. ...